Initial research on the effect and mechanism of Tivozanib on pulsed dye laser induced angiogenesis
Sign Up to like & getrecommendations! Published in 2022 at "Lasers in Surgery and Medicine"
DOI: 10.1002/lsm.23586
Abstract: Pulsed dye laser (PDL) is the main treatment for port wine stain (PWS), but a considerable number of patients show low clearances. The reason for the poor efficacy is related to PDL‐induced angiogenesis. Vascular endothelial… read more here.
Keywords: induced angiogenesis; dye laser; effect; pulsed dye ... See more keywords
Tivozanib for the treatment of advanced renal cell carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2102419
Abstract: ABSTRACT Introduction Renal cell carcinoma (RCC) accounts for 2.4% of cancers, with clear cell kidney cancer being the most common histologic subtype. Despite recent therapeutic advances, the prognosis for patients with advanced disease remains poor,… read more here.
Keywords: cell carcinoma; cell; renal cell; treatment ... See more keywords
The role of tivozanib in advanced renal cell carcinoma therapy
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2018.1508348
Abstract: ABSTRACT Introduction: The efficacy of VEGF-targeting therapies in clinical trials led to their recommendation in clinical guidelines for use across the advanced or metastatic renal cell carcinoma (RCC) treatment landscape, however, tolerability (including off-target effects)… read more here.
Keywords: renal cell; tivozanib; cell carcinoma; tivozanib advanced ... See more keywords
Tivozanib in relapsed or refractory advanced renal cell carcinoma: a focus on US approval
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2088515
Abstract: ABSTRACT Introduction Tivozanib is a selective vascular endothelial growth factor receptor (VEGFR)-inhibitor designed to, more specifically, bind to the VEGF receptor with fewer off-target interactions with other tyrosine kinase receptors in the treatment of advanced… read more here.
Keywords: cell carcinoma; tivozanib; renal cell; relapsed refractory ... See more keywords